AC Immune S.A.

NASDAQ: ACIU · Real-Time Price · USD
2.15
0.02 (0.94%)
At close: Aug 15, 2025, 3:59 PM
2.12
-1.17%
After-hours: Aug 15, 2025, 04:45 PM EDT

AC Immune S.A. Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
28.3M 27.31M 40.97M 15.49M 14.8M 14.8M 1K 3.94M 3.94M 3.94M 3.93M n/a n/a n/a 944K 2.07M 3.35M
Cost of Revenue
17.14M 32.3M 46.95M 59.35M 55.9M 54.61M 55.1M 57.08M 59.09M 60.34M 65.32M 66.06M 64.08M 62.28M 58.11M 58.51M 57.61M
Gross Profit
11.16M -4.99M -5.97M -43.87M -41.1M -39.8M -55.1M -53.14M -55.15M -56.4M -61.39M -66.06M -64.08M -62.28M -57.16M -56.44M -54.26M
Operating Income
-51.68M -52.38M -37.3M -60.04M -56.12M -53.62M -68.78M -66.78M -69.59M -70.85M -74.94M -81.76M -80.59M -79.01M -75.69M -74.21M -71.21M
Interest Income
3.25M 3.2M 2.6M 1.94M 1.46M 1.04M 812K 538K 279K 70K 2.07M 6.49M 6.49M 6.49M 4.42M n/a 17K
Pretax Income
-52.08M -50.91M -39.86M -60.51M -54.58M -54.22M -68.23M -66.6M -69.41M -70.74M -73.27M -75.67M -75.1M -72.99M -71.22M -74.3M -70.97M
Net Income
-52.08M -50.92M -39.86M -60.51M -54.58M -54.23M -68.24M -66.61M -69.42M -70.76M -73.28M -75.69M -75.11M -73M -71.22M -74.3M -70.97M
Selling & General & Admin
10.91M 11.43M 12.6M 12.31M 11.44M 10.58M 9.01M 8.81M 9.51M 9.57M 7.7M 9.85M 10.71M 10.88M 12.53M 12M 10.92M
Research & Development
63.32M 62.57M 61.43M 59.35M 55.9M 54.61M 55.1M 57.08M 59.09M 60.34M 65.32M 66.06M 64.08M 62.28M 58.11M 58.51M 57.61M
Other Expenses
-11.39M -11.39M -17.2M -17.18M n/a -408K 5.4M 5.14M 4.93M 4.88M 5.85M 5.86M 5.81M 5.85M 6M 5.77M 6.03M
Operating Expenses
79.98M 79.69M 78.27M 75.52M 70.92M 68.42M 68.78M 70.71M 73.53M 74.78M 78.87M 81.76M 80.59M 79.01M 76.63M 76.28M 74.55M
Interest Expense
151K 133K 129K 122K 115K 176K 150K 201K 300K 357K 530K 634K 710K 582K 441K 306K 160K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
79.98M 79.69M 78.27M 75.52M 70.92M 68.42M 68.78M 70.71M 73.53M 74.78M 78.87M 81.76M 80.59M 79.01M 76.63M 76.28M 74.55M
Income Tax Expense
3K 39K 37K 40K 43K 10K 11K 12K 12K 13K 14K 10K 7K 29K 23K -123K -119K
Shares Outstanding (Basic)
100.41M 110.06M 110.06M 99.55M 99.39M 86.74M 84.72M 84.61M 83.63M 83.59M 83.59M 84.46M 83.49M 72.89M 72.89M 72.72M 72.31M
Shares Outstanding (Diluted)
100.41M 100.86M 100.86M 99.55M 99.39M 86.74M 84.72M 84.61M 83.63M 83.59M 83.59M 84.46M 83.49M 72.89M 72.89M 72.72M 72.31M
EPS (Basic)
-0.51 -0.5 -0.41 -0.64 -0.61 -0.64 -0.81 -0.79 -0.82 -0.84 -0.91 -0.97 -1 -1 -0.98 -1.02 -0.98
EPS (Diluted)
-0.53 -0.52 -0.41 -0.64 -0.61 -0.64 -0.81 -0.79 -0.82 -0.84 -0.91 -0.97 -1 -1 -0.98 -1.02 -0.98
EBITDA
-49.71M -50.23M -39.16M -59.79M -53.87M -51.83M -65.91M -64.2M -67.22M -68.61M -72.27M -74.52M -73.51M -71.98M -69.03M -72.38M -69.31M
EBIT
-51.93M -50.78M -39.73M -60.38M -54.46M -54.05M -68.08M -66.4M -69.11M -70.39M -72.74M -75.04M -74.39M -72.41M -70.78M -73.99M -70.81M
Depreciation & Amortization
2.22M 2.16M 2.19M 2.21M 2.2M 2.21M 2.27M 2.29M 2.33M 2.36M 2.38M 2.44M 2.46M 2.41M 2.29M 2.16M 2.04M